BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 29449539)

  • 1. G9A promotes gastric cancer metastasis by upregulating ITGB3 in a SET domain-independent manner.
    Hu L; Zang MD; Wang HX; Zhang BG; Wang ZQ; Fan ZY; Wu H; Li JF; Su LP; Yan M; Zhu ZQ; Yang QM; Huang Q; Liu BY; Zhu ZG
    Cell Death Dis; 2018 Feb; 9(3):278. PubMed ID: 29449539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The H3K9 methyltransferase G9a is a marker of aggressive ovarian cancer that promotes peritoneal metastasis.
    Hua KT; Wang MY; Chen MW; Wei LH; Chen CK; Ko CH; Jeng YM; Sung PL; Jan YH; Hsiao M; Kuo ML; Yen ML
    Mol Cancer; 2014 Aug; 13():189. PubMed ID: 25115793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The H3K9 Methyltransferase G9a Represses E-cadherin and is Associated with Myometrial Invasion in Endometrial Cancer.
    Hsiao SM; Chen MW; Chen CA; Chien MH; Hua KT; Hsiao M; Kuo ML; Wei LH
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1556-65. PubMed ID: 25613390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FIH Is an Oxygen Sensor in Ovarian Cancer for G9a/GLP-Driven Epigenetic Regulation of Metastasis-Related Genes.
    Kang J; Shin SH; Yoon H; Huh J; Shin HW; Chun YS; Park JW
    Cancer Res; 2018 Mar; 78(5):1184-1199. PubMed ID: 29259012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulated expression of G9a is correlated with poor prognosis of gastric cancer patients.
    Zhang C; Wei S; Hu J; Xiong Z
    Medicine (Baltimore); 2019 Nov; 98(48):e18212. PubMed ID: 31770281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. G9a-mediated repression of CDH10 in hypoxia enhances breast tumour cell motility and associates with poor survival outcome.
    Casciello F; Al-Ejeh F; Miranda M; Kelly G; Baxter E; Windloch K; Gannon F; Lee JS
    Theranostics; 2020; 10(10):4515-4529. PubMed ID: 32292512
    [No Abstract]   [Full Text] [Related]  

  • 7. G9A promotes tumor cell growth and invasion by silencing CASP1 in non-small-cell lung cancer cells.
    Huang T; Zhang P; Li W; Zhao T; Zhang Z; Chen S; Yang Y; Feng Y; Li F; Shirley Liu X; Zhang L; Jiang G; Zhang F
    Cell Death Dis; 2017 Apr; 8(4):e2726. PubMed ID: 28383547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. H3K9 histone methyltransferase G9a promotes lung cancer invasion and metastasis by silencing the cell adhesion molecule Ep-CAM.
    Chen MW; Hua KT; Kao HJ; Chi CC; Wei LH; Johansson G; Shiah SG; Chen PS; Jeng YM; Cheng TY; Lai TC; Chang JS; Jan YH; Chien MH; Yang CJ; Huang MS; Hsiao M; Kuo ML
    Cancer Res; 2010 Oct; 70(20):7830-40. PubMed ID: 20940408
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone methyltransferase G9a promotes liver cancer development by epigenetic silencing of tumor suppressor gene RARRES3.
    Wei L; Chiu DK; Tsang FH; Law CT; Cheng CL; Au SL; Lee JM; Wong CC; Ng IO; Wong CM
    J Hepatol; 2017 Oct; 67(4):758-769. PubMed ID: 28532996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. REG4 promotes peritoneal metastasis of gastric cancer through GPR37.
    Wang H; Hu L; Zang M; Zhang B; Duan Y; Fan Z; Li J; Su L; Yan M; Zhu Z; Liu B; Yang Q
    Oncotarget; 2016 May; 7(19):27874-88. PubMed ID: 27036049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulated β-arrestin1 predicts poor prognosis and promotes metastasis via AKT/ERK signaling pathway in gastric cancer.
    Xu T; Shen G; Cheng M; Wu X; Xu Y; Hu S
    Pathol Res Pract; 2020 Dec; 216(12):153262. PubMed ID: 33129195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human EHMT2/G9a activates p53 through methylation-independent mechanism.
    Rada M; Vasileva E; Lezina L; Marouco D; Antonov AV; Macip S; Melino G; Barlev NA
    Oncogene; 2017 Feb; 36(7):922-932. PubMed ID: 27452519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-3978 regulates peritoneal gastric cancer metastasis by targeting legumain.
    Zhang Y; Wu YY; Jiang JN; Liu XS; Ji FJ; Fang XD
    Oncotarget; 2016 Dec; 7(50):83223-83230. PubMed ID: 27793040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G9a promotes cell proliferation and suppresses autophagy in gastric cancer by directly activating mTOR.
    Yin C; Ke X; Zhang R; Hou J; Dong Z; Wang F; Zhang K; Zhong X; Yang L; Cui H
    FASEB J; 2019 Dec; 33(12):14036-14050. PubMed ID: 31647887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G9a-mediated methylation of ERα links the PHF20/MOF histone acetyltransferase complex to hormonal gene expression.
    Zhang X; Peng D; Xi Y; Yuan C; Sagum CA; Klein BJ; Tanaka K; Wen H; Kutateladze TG; Li W; Bedford MT; Shi X
    Nat Commun; 2016 Mar; 7():10810. PubMed ID: 26960573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional activation of ANO1 promotes gastric cancer progression.
    Zeng X; Pan D; Wu H; Chen H; Yuan W; Zhou J; Shen Z; Chen S
    Biochem Biophys Res Commun; 2019 Apr; 512(1):131-136. PubMed ID: 30871776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depletion of G9a gene induces cell apoptosis in human gastric carcinoma.
    Lin X; Huang Y; Zou Y; Chen X; Ma X
    Oncol Rep; 2016 May; 35(5):3041-9. PubMed ID: 27081761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sex determining region Y-box 12 (SOX12) promotes gastric cancer metastasis by upregulating MMP7 and IGF1.
    Du F; Feng W; Chen S; Wu S; Cao T; Yuan T; Tian D; Nie Y; Wu K; Fan D; Xia L
    Cancer Lett; 2019 Jun; 452():103-118. PubMed ID: 30922917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of the PTEN-AKT-RAC1 Axis by G9a Is Critical for Tumor Growth in Alveolar Rhabdomyosarcoma.
    Bhat AV; Palanichamy Kala M; Rao VK; Pignata L; Lim HJ; Suriyamurthy S; Chang KT; Lee VK; Guccione E; Taneja R
    Cancer Res; 2019 May; 79(9):2232-2243. PubMed ID: 30833420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting histone methyltransferase G9a inhibits growth and Wnt signaling pathway by epigenetically regulating HP1α and APC2 gene expression in non-small cell lung cancer.
    Zhang K; Wang J; Yang L; Yuan YC; Tong TR; Wu J; Yun X; Bonner M; Pangeni R; Liu Z; Yuchi T; Kim JY; Raz DJ
    Mol Cancer; 2018 Oct; 17(1):153. PubMed ID: 30348169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.